“agios” Archives

in
Entry Author Date Location
Arch’s Bob Nelsen on Big Biotech and Why Pharma Should Be Very Afraid 05/15/18 National
Xconomy Boston’s Top Stories of Q2 2014: Editor’s Picks 07/01/14 Boston
East Coast Life Sciences Roundup: Celgene, Dunsire, Forma, & More 07/12/13 Boston
The Year In New York Biotech—Still Trying to Make It Here 12/28/12 New York
Third Rock’s Mark Levin: ‘Ultra-Super Positive’ on Biotech Innovation 03/29/12 Boston
Celgene Pours $15M Into Acetylon, Takes “Observer” Role on Board 02/09/12 Boston
Celgene Buys Avila for $350M, Gaining Promising “Covalent” Drugs 01/26/12 Boston
Flagship Closes New $270M Fund For Healthcare and Cleantech Ventures 01/11/12 Boston
Allena Kicks Off With $15M, Security Firms Ink Funding, TeraDiode Takes In $10M, & More Boston-Area Deals News 11/23/11 Boston
Agios Nabs $78M From Partner Celgene, Existing VCs, and Public Funds 11/17/11 Boston
Agios and Celgene: Anatomy of an Ultra-Valuable Biotech Marriage 10/11/11 Boston
David Berry of Flagship Ventures on Funding Advice, Investment Themes, Trends in Biofuels 05/12/10 Seattle
Boston Scientific Wins Stent Approval, Resolvyx Moves Closer to Fish-Oil Drug Trials, Codon Cuts Algae Fuel Deal, & More Life Sciences News 07/09/08 Boston
Page 1 of 1